human leukemic jurkat e6.1 cell line (European Collection of Authenticated Cell Cultures)
Structured Review

Human Leukemic Jurkat E6.1 Cell Line, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human leukemic jurkat e6.1 cell line/product/European Collection of Authenticated Cell Cultures
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Cultured lymphocytes’ mitochondrial genome integrity is not altered by cladribine"
Article Title: Cultured lymphocytes’ mitochondrial genome integrity is not altered by cladribine
Journal: Clinical and Experimental Immunology
doi: 10.1093/cei/uxad112
Figure Legend Snippet: Proliferation rates of the T-cell lines and effects of cladribine on cell viability. (a) The growth rate of Jurkat E6.1 is faster than the CCRF-CEM cell line ( n = 3). (b) A cladribine dose response curve in Jurkat E6.1 cell line for cell proliferation with 48 hours ( n = 5) and 96 hours culture ( n = 5). (c) The effect of cladribine on cell proliferation in Jurkat with 12 days ( n = 5) and 16 days in culture ( n = 5). (d) The effect of cladribine on cell proliferation in CCRF-CEM with 2 days ( n = 5), 8 days ( n = 4), and 12 days ( n = 4) in culture ( n = 5).
Techniques Used:
Figure Legend Snippet: Effect of cladribine on mitochondrial protein synthesis. (a) Immunoblot of MT-ATP6, MT-CO1, MRPL11, MRPS35, CASPASE3, SDHA, and CANX after 12 days culture with cladribine. In this experiment, 10 nM cladribine in CCRF cells resulted in extensive cell death, and immunoblot was not performed. (b) A pulse metabolic labeling of mitochondrial protein synthesis. The effect on mitochondrial protein synthesis in the CCRF-CEM and Jurkat cells after treatment with cladribine for 8 days ( n = 3) or 12 days ( n = 3).
Techniques Used: Western Blot, Labeling
